{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:30:21Z","timestamp":1772620221778,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.atherosclerosis.2009.05.023","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T08:36:41Z","timestamp":1243499801000},"page":"579-584","source":"Crossref","is-referenced-by-count":15,"title":["Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia"],"prefix":"10.1016","volume":"207","author":[{"given":"Tetsuo","family":"Shoji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Hatsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Tsuchikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusuke","family":"Kakiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000063557","article-title":"Uremia-specific alterations in lipid metabolism","volume":"20","author":"Wanner","year":"2002","journal-title":"Blood Purif"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1744-9987.2006.00382.x","article-title":"Plasma lipoprotein abnormalities in hemodialysis patients\u2014clinical implications and therapeutic guidelines","volume":"10","author":"Shoji","year":"2006","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.V971277","article-title":"Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients","volume":"9","author":"Shoji","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9150(00)00529-3","article-title":"Additive impacts of diabetes and renal failure on carotid atherosclerosis","volume":"153","author":"Shoji","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib5","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1046\/j.1523-1755.2002.00372.x","article-title":"Advanced atherosclerosis in predialysis patients with chronic renal failure","volume":"61","author":"Shoji","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1523-1755.2004.00468.x","article-title":"Arterial stiffness in predialysis patients with uremia","volume":"65","author":"Shinohara","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ki.1980.196","article-title":"Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia","volume":"18","author":"Savdie","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib8","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1161\/01.ATV.0000188555.60475.c2","article-title":"Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis","volume":"25","author":"Ikewaki","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-2275(20)37713-0","article-title":"High density lipoprotein metabolism","volume":"25","author":"Eisenberg","year":"1984","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib10","first-page":"648","article-title":"Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients","volume":"87","author":"Ibels","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM197712222972502","article-title":"Selective deficiency of hepatic triglyceride lipase in uremic patients","volume":"297","author":"Mordasini","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib12","doi-asserted-by":"crossref","first-page":"297S","DOI":"10.1093\/ajcn\/56.1.297S","article-title":"High-density-lipoprotein metabolism during a very-low-calorie diet","volume":"56","author":"Shoji","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0026-0495(75)90066-9","article-title":"Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia","volume":"24","author":"Murase","year":"1975","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng814","article-title":"Angptl3 regulates lipid metabolism in mice","volume":"30","author":"Koishi","year":"2002","journal-title":"Nat Genet"},{"issue":"Pt 3","key":"10.1016\/j.atherosclerosis.2009.05.023_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1042\/0264-6021:3460603","article-title":"Hepatic expression, synthesis and secretion of a novel fibrinogen\/angiopoietin-related protein that prevents endothelial-cell apoptosis","volume":"346","author":"Kim","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib16","doi-asserted-by":"crossref","first-page":"33742","DOI":"10.1074\/jbc.M203215200","article-title":"ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase","volume":"277","author":"Shimizugawa","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0006-291X(02)03058-9","article-title":"Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes","volume":"301","author":"Shimamura","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(97)00054-3","article-title":"Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis","volume":"131","author":"Shoji","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9150(00)00673-0","article-title":"Atherogenic lipoprotein changes in diabetic nephropathy","volume":"156","author":"Shoji","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000098153","article-title":"Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects","volume":"44","author":"Hatsuda","year":"2007","journal-title":"J Vasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/diacare.22.5.818","article-title":"Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas","volume":"22","author":"Emoto","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib23","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1016\/S0021-9258(18)88863-9","article-title":"Molecular size of bovine lipoprotein lipase as determined by radiation inactivation","volume":"260","author":"Olivecrona","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0005-2760(89)90231-2","article-title":"Purification and characterization of lipoprotein lipase and hepatic triglyceride lipase from human postheparin plasma: production of monospecific antibody to the individual lipase","volume":"1003","author":"Ikeda","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/bi00733a026","article-title":"Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources","volume":"12","author":"Havel","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib26","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI117151","article-title":"Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice","volume":"93","author":"Shachter","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.ATV.0000252827.51626.89","article-title":"Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase","volume":"27","author":"Shimamura","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2007.12.031","article-title":"Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling","volume":"200","author":"Miida","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2009.05.023_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2008.08.021","article-title":"Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects","volume":"398","author":"Moon","year":"2008","journal-title":"Clin Chim Acta"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500900416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191500900416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T09:12:08Z","timestamp":1633511528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191500900416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S002191500900416X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.05.023","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}